The IC50 values of drug-sensitive SCLC cells (H69, H446, H146, and H1688 cells) treated with chemotherapeutic drugs were significantly increased with the EPHA3 deficiency, while the drug-resistance of H69AR cells was further enhanced (**P < 0.05; Fig. 3c). This evidence concerns the gene EPHA3 and small cell lung carcinoma.